Recombinant Insulin API Powder from Canada
Bulk active pharmaceutical ingredient powder of human insulin produced by recombinant E. coli or yeast. HTS 2937.12.00.00 for pure synthetic insulin substance before formulation into dosage forms.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Reference Drug Master File (DMF) with FDA; provide manufacturing process validation
• Lyophilized powder stable at 2-8°C; avoid freeze-thaw cycles in transit
• Bulk API declaration prevents erroneous Chapter 30 pharmaceutical classification